Nautilus Biotechnology (NAUT)'s 30-day implied volatility (IV30) was 131.6% at the close on October 21, 2026, down from 142.1% the day before, against a 52-week range of 60.1% to 212.6%. Its 20-day historical volatility was 189.4%.
Data as of October 21, 2026.